Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Beta2-adrenergic receptor homodimers: Role of transmembrane domain 1 and helix 8 in dimerization and cell surface expression.

Parmar VK, Grinde E, Mazurkiewicz JE, Herrick-Davis K.

Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt A):1445-1455. doi: 10.1016/j.bbamem.2016.12.007. Epub 2016 Dec 18.

2.

Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor.

Mazurkiewicz JE, Herrick-Davis K, Barroso M, Ulloa-Aguirre A, Lindau-Shepard B, Thomas RM, Dias JA.

Biol Reprod. 2015 Apr;92(4):100. doi: 10.1095/biolreprod.114.125781. Epub 2015 Mar 11.

3.

Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells.

Herrick-Davis K, Grinde E, Lindsley T, Teitler M, Mancia F, Cowan A, Mazurkiewicz JE.

Mol Pharmacol. 2015 Apr;87(4):660-73. doi: 10.1124/mol.114.096636. Epub 2015 Jan 21.

4.
5.

Fluorescence correlation spectroscopy and photon-counting histogram analysis of receptor-receptor interactions.

Herrick-Davis K, Mazurkiewicz JE.

Methods Cell Biol. 2013;117:181-96. doi: 10.1016/B978-0-12-408143-7.00010-4.

PMID:
24143978
6.

Fluorescence correlation spectroscopy analysis of serotonin, adrenergic, muscarinic, and dopamine receptor dimerization: the oligomer number puzzle.

Herrick-Davis K, Grinde E, Cowan A, Mazurkiewicz JE.

Mol Pharmacol. 2013 Oct;84(4):630-42. doi: 10.1124/mol.113.087072. Epub 2013 Aug 1.

7.

Functional significance of serotonin receptor dimerization.

Herrick-Davis K.

Exp Brain Res. 2013 Oct;230(4):375-86. doi: 10.1007/s00221-013-3622-1. Epub 2013 Jun 29. Review.

8.

RNA splicing and editing modulation of 5-HT(2C) receptor function: relevance to anxiety and aggression in VGV mice.

Martin CB, Ramond F, Farrington DT, Aguiar AS Jr, Chevarin C, Berthiau AS, Caussanel S, Lanfumey L, Herrick-Davis K, Hamon M, Madjar JJ, Mongeau R.

Mol Psychiatry. 2013 Jun;18(6):656-65. doi: 10.1038/mp.2012.171. Epub 2012 Dec 18.

PMID:
23247076
9.

Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.

Herrick-Davis K, Grinde E, Lindsley T, Cowan A, Mazurkiewicz JE.

J Biol Chem. 2012 Jul 6;287(28):23604-14. doi: 10.1074/jbc.M112.350249. Epub 2012 May 16.

10.

Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.

Herrick-Davis K, Grinde E, Weaver BA.

Eur J Pharmacol. 2007 Jul 30;568(1-3):45-53. Epub 2007 May 4.

11.

Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.

Smith C, Rahman T, Toohey N, Mazurkiewicz J, Herrick-Davis K, Teitler M.

Mol Pharmacol. 2006 Oct;70(4):1264-70. Epub 2006 Jul 26.

PMID:
16870886
12.

Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer.

Herrick-Davis K, Weaver BA, Grinde E, Mazurkiewicz JE.

J Biol Chem. 2006 Sep 15;281(37):27109-16. Epub 2006 Jul 20.

13.

Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.

Herrick-Davis K, Grinde E, Harrigan TJ, Mazurkiewicz JE.

J Biol Chem. 2005 Dec 2;280(48):40144-51. Epub 2005 Sep 29.

14.

Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms.

Fentress HM, Grinde E, Mazurkiewicz JE, Backstrom JR, Herrick-Davis K, Sanders-Bush E.

Pharmacogenomics J. 2005;5(4):244-54.

PMID:
15912142
15.

Actions of tacrine and galanthamine on histamine-N-methyltransferase.

Taraschenko OD, Barnes WG, Herrick-Davis K, Yokoyama Y, Boyd DL, Hough LB.

Methods Find Exp Clin Pharmacol. 2005 Apr;27(3):161-5.

PMID:
15834447
16.

Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.

Purohit A, Smith C, Herrick-Davis K, Teitler M.

Psychopharmacology (Berl). 2005 May;179(2):461-9. Epub 2004 Dec 10.

PMID:
15821958
17.

Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.

Herrick-Davis K, Grinde E, Mazurkiewicz JE.

Biochemistry. 2004 Nov 9;43(44):13963-71.

PMID:
15518545
18.

Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.

Dukat M, Smith C, Herrick-Davis K, Teitler M, Glennon RA.

Bioorg Med Chem. 2004 May 15;12(10):2545-52.

PMID:
15110837
19.

Characterization of a new mRNA species from the human histamine N-methyltransferase gene.

Barnes WG, Grinde E, Crawford DR, Herrick-Davis K, Hough LB.

Genomics. 2004 Jan;83(1):168-71.

PMID:
14667820
20.

Binding of beta-carbolines at 5-HT(2) serotonin receptors.

Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA.

Bioorg Med Chem Lett. 2003 Dec 15;13(24):4421-5.

PMID:
14643338
21.

Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: a QSAR study.

Glennon RA, Daoud MK, Dukat M, Teitler M, Herrick-Davis K, Purohit A, Syed H.

Bioorg Med Chem. 2003 Oct 1;11(20):4449-54.

PMID:
13129581
22.

Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.

Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA.

J Med Chem. 2003 Aug 28;46(18):3930-7.

PMID:
12930153
23.

Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).

Rahman AA, Daoud MK, Dukat M, Herrick-Davis K, Purohit A, Teitler M, do Amaral AT, Malvezzi A, Glennon RA.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1119-23. Erratum in: Bioorg Med Chem Lett. 2012 Oct 15;22(20):6526.

PMID:
12643925
24.

gamma-Carbolines: binding at 5-HT5A serotonin receptors.

Khorana N, Purohit A, Herrick-Davis K, Teitler M, Glennon RA.

Bioorg Med Chem. 2003 Mar 6;11(5):717-22.

PMID:
12538001
25.
26.

Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors.

Teitler M, Herrick-Davis K, Purohit A.

Curr Top Med Chem. 2002 Jun;2(6):529-38. Review.

PMID:
12052192
27.

Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors.

Chang-Fong J, Addo J, Dukat M, Smith C, Mitchell NA, Herrick-Davis K, Teitler M, Glennon RA.

Bioorg Med Chem Lett. 2002 Jan 21;12(2):155-8.

PMID:
11755343
28.

1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character.

Rangisetty JB, Dukat M, Dowd CS, Herrick-Davis K, DuPre A, Gadepalli S, Teitler M, Kelley CR, Sharif NA, Glennon RA.

J Med Chem. 2001 Sep 27;44(20):3283-91.

PMID:
11563927
29.

The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.

Dukat M, Choi YN, Teitler M, Du Pre A, Herrick-Davis K, Smith C, Glennon RA.

Bioorg Med Chem Lett. 2001 Jun 18;11(12):1599-603.

PMID:
11412989
30.

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.

Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E.

Neuropsychopharmacology. 2001 May;24(5):478-91.

31.

Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.

Herrick-Davis K, Grinde E, Teitler M.

J Pharmacol Exp Ther. 2000 Oct;295(1):226-32.

PMID:
10991983
32.

Behavioural sensitization to cocaine is dissociated from changes in striatal NMDA receptor levels.

Szumlinski KK, Herrick-Davis K, Teitler M, Maisonneuve IM, Glick SD.

Neuroreport. 2000 Aug 21;11(12):2785-8.

PMID:
10976963
33.

1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.

Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA.

J Med Chem. 2000 Aug 10;43(16):3074-84.

PMID:
10956215
34.

Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.

Egan C, Grinde E, Dupre A, Roth BL, Hake M, Teitler M, Herrick-Davis K.

Synapse. 2000 Feb;35(2):144-50.

PMID:
10611640
35.
36.

RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.

Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E.

J Biol Chem. 1999 Apr 2;274(14):9472-8.

37.

Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.

Herrick-Davis K, Grinde E, Gauthier C, Teitler M.

Ann N Y Acad Sci. 1998 Dec 15;861:140-5.

PMID:
9928251
38.
39.

Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.

Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA.

J Med Chem. 1998 Dec 3;41(25):5084-93.

PMID:
9836624
41.

Investigation of hallucinogenic and related beta-carbolines.

Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB, Glennon RA.

Drug Alcohol Depend. 1998 Apr 1;50(2):99-107.

PMID:
9649961
42.

Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.

Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M.

Psychopharmacology (Berl). 1998 Apr;136(4):409-14.

PMID:
9600588
43.

Activating mutations of the serotonin 5-HT2C receptor.

Herrick-Davis K, Egan C, Teitler M.

J Neurochem. 1997 Sep;69(3):1138-44.

44.

Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.

Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhi S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C.

J Med Chem. 1996 Jan 5;39(1):314-22.

PMID:
8568822
45.

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine.

Pearl SM, Herrick-Davis K, Teitler M, Glick SD.

Brain Res. 1995 Mar 27;675(1-2):342-4.

PMID:
7796150
46.

Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines.

Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K.

J Med Chem. 1994 Jun 24;37(13):1929-35.

PMID:
8027974
47.

Multiple serotonin receptor subtypes: molecular cloning and functional expression.

Teitler M, Herrick-Davis K.

Crit Rev Neurobiol. 1994;8(3):175-88. Review.

PMID:
7923395
48.

Modulation of neurite outgrowth in neuroblastoma cells by protein kinase C and platelet-activating factor.

Herrick-Davis K, Camussi G, Bussolino F, Baglioni C.

J Biol Chem. 1991 Oct 5;266(28):18620-5.

49.

Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.

Tetta C, Camussi G, Bussolino F, Herrick-Davis K, Baglioni C.

J Pharmacol Exp Ther. 1991 May;257(2):616-20.

PMID:
2033508
50.

Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein.

Leonhardt S, Herrick-Davis K, Titeler M.

J Neurochem. 1989 Aug;53(2):465-71.

PMID:
2664084

Supplemental Content

Loading ...
Support Center